GENNARELLI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 15.532
EU - Europa 6.276
AS - Asia 3.393
SA - Sud America 22
Continente sconosciuto - Info sul continente non disponibili 21
AF - Africa 17
OC - Oceania 17
AN - Antartide 1
Totale 25.279
Nazione #
US - Stati Uniti d'America 15.488
CN - Cina 2.270
UA - Ucraina 1.932
PL - Polonia 1.070
DE - Germania 785
IT - Italia 785
HK - Hong Kong 565
FI - Finlandia 423
FR - Francia 419
GB - Regno Unito 386
IE - Irlanda 321
SG - Singapore 318
IN - India 93
VN - Vietnam 68
CA - Canada 39
BE - Belgio 37
SE - Svezia 35
TR - Turchia 34
CZ - Repubblica Ceca 30
EU - Europa 21
BR - Brasile 18
AU - Australia 16
IR - Iran 16
NL - Olanda 15
CH - Svizzera 9
MU - Mauritius 7
RU - Federazione Russa 7
BG - Bulgaria 5
EG - Egitto 4
IL - Israele 4
JP - Giappone 4
KR - Corea 4
RO - Romania 4
SA - Arabia Saudita 4
ES - Italia 3
ZA - Sudafrica 3
HN - Honduras 2
HU - Ungheria 2
ID - Indonesia 2
LU - Lussemburgo 2
MA - Marocco 2
PA - Panama 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
CL - Cile 1
EC - Ecuador 1
EE - Estonia 1
GR - Grecia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
TH - Thailandia 1
TN - Tunisia 1
Totale 25.279
Città #
Fairfield 2.491
Woodbridge 1.991
Jacksonville 1.428
Houston 1.264
Ashburn 1.118
Ann Arbor 1.074
Warsaw 1.070
Cambridge 1.007
Seattle 921
Wilmington 825
Chandler 654
Princeton 602
Hong Kong 562
Nanjing 516
Dublin 317
Beijing 289
Brescia 268
New York 244
Dearborn 230
Nanchang 210
Singapore 196
Helsinki 178
Des Moines 158
Shenyang 153
Hebei 139
San Diego 131
Changsha 126
Lancaster 100
Jinan 99
Shanghai 92
Milan 88
Jiaxing 83
Tianjin 83
Dong Ket 68
Kunming 63
Verona 59
Norwalk 57
Boardman 54
Hangzhou 53
Lanzhou 48
Zhengzhou 48
Ningbo 47
London 41
Haikou 38
Brussels 36
San Mateo 34
Bolzano 32
Los Angeles 30
San Francisco 30
Leawood 27
Brno 26
Guangzhou 24
Kocaeli 24
Washington 22
Fuzhou 21
Augusta 19
Changchun 18
Hefei 18
Munich 18
Orange 17
Kilburn 16
Taizhou 16
Toronto 16
Ardabil 14
Taiyuan 12
Naples 10
Chiswick 9
Hounslow 9
Lappeenranta 8
Phoenix 8
Québec 8
Rome 8
San Donà Di Piave 8
Chicago 7
Redwood City 7
Basel 6
Canberra 6
Guastalla 6
New Bedfont 6
Casalmaggiore 5
Crotone 5
Falkenstein 5
Mantova 5
Markham 5
Monmouth Junction 5
Redmond 5
Acton 4
Ansbach 4
Chongqing 4
Gunzenhausen 4
Melbourne 4
Montreal 4
Olomouc 4
Ottawa 4
Pieve D'alpago 4
Providence 4
Pune 4
Schio 4
Sydney 4
Wandsworth 4
Totale 19.950
Nome #
New Copy Number Variations in Schizophrenia 260
Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling 260
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 257
The effect of childhood trauma on blood transcriptome expression in major depressive disorder 219
Compound heterozygosity for a large CNV deletion and a rare missense mutation in the FSTL5 gene of a patient affected by schizophrenia. 204
Mutation within TARDBP leads to Frontotemporal Dementia without motor neuron disease. 200
Compound heterozygosity for a hemizygous rare missense variant (rs141999351) and a large CNV deletion affecting the FSTL5 gene in a patient with schizophrenia 172
Genome-wide analysis of consistently RNA edited sites in human blood reveals interactions with mRNA processing genes and suggests correlations with cell types and biological variables 172
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 165
New biological pathways for major depression: gene expression decomposition in G x E components 157
Reduced function of the serotonin transporter is associated with decreased expression of BDNF in rodents as well as in humans. 157
Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder Patients 156
Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood 155
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 154
Copy number variants in attention-deficit hyperactive disorder: identification of the 15q13 deletion and its functional role. 147
Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment. 142
The role of the potassium channel gene KCNK2 in major depressive disorder 142
Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. 141
Genomic restricted maximum likelihood (GREML) analysis to estimate the heritability of response/resistance in major depressive disorder (MDD) 140
TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course. 137
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. 137
Acute Footshock Stress Induces Time-Dependent Modifications of AMPA/NMDA Protein Expression and AMPA Phosphorylation 136
The MCP-1 gene (SCYA2) and mood disorders: preliminary results of a case-control association study. 133
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 130
Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder 126
Gene per la neuregulina 1 e schizofrenia: ulteriori evidenze di associazione 123
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 122
Next Generation Sequencing Analysis in Early Onset Dementia Patients 122
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues 121
Acute Stress Responsiveness of the Neurotrophin BDNF in the Rat Hippocampus is Modulated by Chronic Treatment with the Antidepressant Duloxetine. 120
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 120
Supporting evidence for using biomarkers in the diagnosis of MCI due to AD 120
Glucose metabolism alterations in patients with bipolar disorder 118
A genome-wide investigation of SNPs and CNVs in schizophrenia. 117
3' UTR (AGG)n repeat of glial cell line-derived neurotrophic factor (GDNF) gene polymorphism in schizophrenia. 116
5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression 116
The Expression of VGF is Reduced in Leukocytes of Depressed Patients and it is Restored by Effective Antidepressant Treatment 116
Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease 115
Association study and mutational screening of SYNGR1 as a candidate susceptibility gene for schizophrenia 113
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. 113
Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline 'Predictors' and Longitudinal 'Targets' 112
MTHFR: Genetic variants, expression analysis and COMT interaction in major depressive disorder 112
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 111
ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder. 111
A putative regulatory subunit (NR3A) of the NMDA receptor complex as candidate gene for susceptibility to schizophrenia: a case-control study. 111
BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects. 110
The Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders 110
Peripheral whole blood microRNA alterations in major depression and bipolar disorder 108
TWO PEDIGREES OF AUTOSOMAL DOMINANT ATRIOVENTRICULAR CANAL DEFECT (AVCD): EXCLUSION FROM THE CRITICAL REGION ON 8p. 107
BDNF Val66Met polymorphism and protein levels in amniotic fluid. 107
Possible Influence of a Non-Synonymous Polymorphism Located in the NGF Precursor on Susceptibility to Late-Onset Alzheimer's Disease and Mild Cognitive Impairment. 107
The role of GRIK4 gene in treatment-resistant depression 107
Alterations of Brain-Derived Neurotrophic Factor Serum Levels in Patients with Alcohol Dependence. 106
Seizure Adequacy Markers and the Prediction of Electroconvulsive Therapy Response 106
The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia 106
BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients 106
Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders. 106
Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. 105
Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes. 105
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients. 104
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders. 104
STUDY OF THE EFFECTS ON DNA OF ELECTROMAGNETIC FIELDS USING CLAMPED HOMOGENEOUS ELECTRIC FIELD GEL ELECTROPHORESIS. 103
Polymorphic CA repeat in IGF-I gene: lack of association with schizophrenia. 103
Molecular signature of disease onset in granulin mutation carriers: a gene expression analysis study. 103
Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series 103
Functional study of a novel homozygous mutation in the GAD1 gene, detected in a patient with schizophrenia. 103
An association of GRIK3 Ser310Ala functional polymorphism with personality traits. 101
Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: Comparison with methylphenidate. 101
The influence of psychiatric screening in healthy populations selection: a new study and meta-analysis of functional 5-HTTLPR and rs25531 polymorphisms and anxiety-related personality traits. 101
INFLAMMATORY AND NEUROTROPHIC FACTORS UNBALANCE IN LEUKOCYTES OF FIRST EPISODE PSYCHOSIS PATIENTS 101
Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis. 101
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 101
Prediction of myotonic dystrophy clinical severity based on the number of intragenic [CTG]n trinucleotide repeats. 100
Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia: a case-control study. 100
Heterozygous TREM2 mutations in frontotemporal dementia 100
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 100
VEGF Haplotypes are Associated with Increased Risk to Progressive Supranuclear Palsy and Corticobasal Syndrome. 99
Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis. 99
GENOTYPING OF SPINAL MUSCULAR ATROPHY FAMILIES WITH LINKED DNA PROBES. 98
Serum sortilin-derived propeptides concentrations are decreased in major depressive disorder patients 98
Long-Term duloxetine treatment normalizes altered brain-derived neurotrophic factor expression in serotonin transporter knockout rats through the modulation of specific neurotrophin isoforms. 97
Genetic Variation in the G720/G30 Gene Locus (DAOA) Influences the Occurrence of Psychotic Symptoms in Patients with Alzheimer's Disease. 97
MEIOTIC DRIVE AT THE MYOTONIC DYSTROPHY LOCUS. 96
Clinical and medial temporal features in a family with mood disorders. 96
Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels 96
A genome-wide pharmacogenomic study of patients with schizophrenia suggests that GRM7 mediates the effects of risperidone on positive symptoms 96
Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation. 96
Genetic Counseling and Testing for Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol. 96
Immune and metabolic alterations in first episode psychosis (FEP) patients 96
COGNITIVE IMPAIRMENT AND (CTG)n EXPANSION IN MYOTONIC DYSTROPHY PATIENTS. 95
Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients. 95
Influence of GRIK4 genetic variants on the electroconvulsive therapy response 95
Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation. 94
MALE HYPOGONADISM IN MYOTONIC DYSTROPHY IS RELATED TO (CTG)n TRIPLET MUTATION. 94
A single polymerase chain reaction-based protocol for detecting normal and expanded alleles in myotonic dystrophy. 94
EXPANSION OF THE MYOTONIC DYSTROPHY GENE IN ITALIAN AND SPANISH PATIENTS 94
Antidepressants activate CaMKII in neuron cell body by Thr286 phosphorylation. 94
Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus 94
Genetic variations and association. 94
PCLO gene: Its role in vulnerability to major depressive disorder. 94
Totale 12.050
Categoria #
all - tutte 120.943
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.943


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.995 1.083 292 275 923 461 905 743 891 563 902 530 427
2020/20214.626 105 495 186 537 220 500 213 513 683 414 550 210
2021/20222.396 158 541 56 56 14 98 206 142 172 238 206 509
2022/20232.084 349 12 31 146 190 620 6 208 315 32 94 81
2023/20242.135 127 52 188 131 95 349 60 72 588 37 37 399
2024/202534 34 0 0 0 0 0 0 0 0 0 0 0
Totale 25.764